This is the authors' abstract. We don't add key points for this paper.
Improving patient access to cancer clinical trials is a fundamental ASCO priority because clinical cancer research is the essential link transforming biomedical discoveries into meaningful progress in cancer care and patient outcomes. Today's standard of care emerged from yesterday's clinical trials. However, numerous barriers continue to threaten patient access to cancer clinical trials. This Special Report describes the essential role clinical trials play in improving cancer care and patient outcomes, current challenges in the design and conduct of clinical trials, and steps taken by ASCO to make clinical trials more accessible, patient-centered, and embedded within the communities where people live.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Balogh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: